Our Timeline
-
2026
ISIDORe II launches, in continuation of the ISIDORe project. This is the first EU project where EVA AISBL participates under its new status, leading workpackage 7, responsible for reference material provision to the ISIDORe II consortium partners.
-
2025
EVA AISBL is founded as an international non-profit association under Belgian law, laying the foundation for stable governance and sustainable research infrastructure in virology.
-
2024
The EVORA project launches, financed by HORIZON-INFRA-DEV-01 under the grant agreement 101131959. Coordinated by EVA, EVORA unites three European RIs (EVA, ERINHA and ELIXIR), under an alliance aimed at reinforcing EU preparedness and response.
-
2020
EVA-G (European Virus Archive Global) receives funding from the European Union's Horizon 2020 research and innovation programme No 871029. The consortium now gathers 36 partners, including 10 non-EU institutions.
-
2017
The EVAg project is interconnected with the Infravec2 European project (H2020) that can provide end-users with insect vectors infected with some of the EVAg viruses.
-
2015
The European Virus Archive goes global (EVAg) becomes a European project of the Horizon 2020 - Research and Innovation Framework Programme, under grant agreement 653316. The EVA project (FP7) was a proof of concept and serves as a robust foundation to build a new and significantly improved project: EVAg includes an international group of 25 laboratories with 16 EU member state institutions and 9 non-EU institutions.
-
2014
EVA, in its fifth year of running under FP7, has evolved highly effective operational procedures and approximately 2000 products have been distributed worldwide. One of EVA’s major contributions is in the control of the emerging MERS-CoV disease in Saudi Arabia. EVA has provided PCR control materials to 151 laboratories worldwide in 54 countries. In addition to sending these materials directly to laboratories at no cost, EVA has provided reagents, free of charge, to WHO regional offices, including the Regional Office for South-East Asia (SEARO) and the Regional Office for the Western Pacific (WPRO).
-
2012
On December 2012, the WHO in its interim guidelines on “Laboratory testing for novel coronavirus”, recommended PCR assays as the method to detect the virus in blood samples. The European Virus Archive was mentioned in the referenced guidelines, as the provider of these assay reagents (positive controls). On request, and with assistance from the WHO, EVA has provided PCR reagents, free of charge in the context of its Trans-national Access activities, to institutions and hospitals worldwide.
-
2010
The EVA project releases its first web-based catalogue; a user-friendly interface that enables end-users to place online enquiries.
-
2009
The European Virus Archive (EVA) project starts, funded by the European Union Seventh Framework Programme (FP7) under grant agreement n°228292. EVA mobilises a European network of expert academic institutes with expertise in collecting, amplifying, characterising, standardising, authenticating, distributing viruses and derived products, with an emphasis on arboviruses.